PROGRAMME 2025

Racing Against Resistance: The Future of Antimicrobials

Chair: Stephan Harbarth, Geneva

08:30

Opening of Registration Desk

09:00 

Welcome addresses: SGPM, Swiss RTA, SSID
Thirty years of Pharmaceutical Medicine

 INTRODUCTION

SESSION I: The Global Health Threat

09:30-10:10      
Are we running out of antibiotics?
Silvio Brugger, University Hospital Zurich

10:10-10:30      
The role of effective antibiotics in modern cancer care
Maribeth Walker, Union for International Cancer Control (UICC)

10:30-11:00      
Coffee Break

Session II: Antimicrobial Resistance and Use Monitoring

11:00-11:15      
AMR* surveillance and antibiotic use monitoring in Switzerland
Catherine Plüss, University of Bern, ANRESIS

11:15-11:30      
Monitoring the use of antibiotics in Switzerland
speaker Helsana, Helsana Zurich

SESSION III: Innovation Challenges in Antibiotic R&D*

11:30-12:00      
Interdisciplinary collaboration bridging academia, industry, and policymakers to overcome funding gaps and accelerate translational research
Henni-Karoliina Ropponen, AMR Action Fund

12:00-12:30      
From basic research to accelerating product innovation
Christoph Dehio, University of Basel  

12:30-13:30      
Lunch

13:30-14:00      

Translational challenges in clinical development
Caterina Bissantz, F. Hoffmann-La Roche, Basel (invited)

14:00-14:30      

Regulatory challenges presented by innovative clinical development strategies
Philippe Girard, Swissmedic, Bern (invited)

14:30-15:00      
Coffee Break

Session IV: Fostering Availability of and Access to Antibiotics

15:00-15:30      
Innovative market incentives to stimulate antibiotic R&D* and availability of new antibiotics
Chantal Morel, University of Bern

15:30-16:00      
Strategy on antibiotic resistance Switzerland (STAR)                           
Kathrin Leventhal, Federal Office of Public Health, Bern 

Session IV: Podium:  New Approaches to Address Antimicrobial Resistance

16:00-17:00      

Moderator: Stephan Harbarth or Stefan Kuster
Chantal Morel, Uni Bern
Kathrin Leventhal, Federal Office of Public Health
Philipp Girard, Swissmedic
Christoph Dehio, Uni Basel
Caterina Bissantz, F. Hoffmann-La Roche
Henni-Karoliina Ropponen, AMR Action Fund 

17:00                 
Résumé by SGPM President

* AMR: antimicrobial resistance / * R&D: research and development